Cardlytics (NASDAQ:CDLX) Receives New Coverage from Analysts at Craig Hallum

Share on StockTwits

Research analysts at Craig Hallum began coverage on shares of Cardlytics (NASDAQ:CDLX) in a report released on Monday, MarketBeat reports. The brokerage set a “buy” rating and a $75.00 price target on the stock. Craig Hallum’s price objective indicates a potential upside of 21.52% from the company’s current price.

Other equities research analysts have also issued reports about the stock. JPMorgan Chase & Co. lowered shares of Cardlytics from an “overweight” rating to a “neutral” rating and set a $58.00 price objective for the company. in a report on Thursday, November 14th. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of Cardlytics from a “hold” rating to a “buy” rating and set a $63.00 price objective on the stock in a research report on Monday, November 18th. SunTrust Banks boosted their target price on shares of Cardlytics from $25.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, August 9th. ValuEngine lowered shares of Cardlytics from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd. Finally, Raymond James upped their target price on shares of Cardlytics from $40.00 to $53.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a sell rating, one has given a hold rating and seven have given a buy rating to the company’s stock. Cardlytics has a consensus rating of “Buy” and a consensus target price of $48.86.

NASDAQ CDLX opened at $61.72 on Monday. Cardlytics has a twelve month low of $9.80 and a twelve month high of $61.98. The business has a 50-day moving average price of $46.78 and a 200-day moving average price of $33.98. The firm has a market cap of $1.41 billion, a price-to-earnings ratio of -28.84 and a beta of 1.71.

Cardlytics (NASDAQ:CDLX) last issued its earnings results on Tuesday, November 12th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.31. Cardlytics had a negative return on equity of 44.53% and a negative net margin of 17.01%. The company had revenue of $56.42 million for the quarter, compared to the consensus estimate of $50.02 million. During the same quarter last year, the company earned ($0.15) EPS. The firm’s quarterly revenue was up 63.2% on a year-over-year basis. On average, sell-side analysts forecast that Cardlytics will post -1.01 earnings per share for the current fiscal year.

In other Cardlytics news, Director Bryce Youngren sold 100,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $58.91, for a total transaction of $5,891,000.00. Following the completion of the transaction, the director now owns 8,484 shares in the company, valued at approximately $499,792.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director David Leslie Adams sold 23,750 shares of Cardlytics stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $58.75, for a total value of $1,395,312.50. Following the completion of the sale, the director now directly owns 41,770 shares in the company, valued at approximately $2,453,987.50. The disclosure for this sale can be found here. Over the last quarter, insiders purchased 316,475 shares of company stock worth $11,914,849 and sold 926,561 shares worth $37,775,884. 21.90% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently modified their holdings of the company. Grantham Mayo Van Otterloo & Co. LLC bought a new position in shares of Cardlytics during the 2nd quarter valued at approximately $10,392,000. Bank of America Corp DE raised its stake in Cardlytics by 17.6% during the second quarter. Bank of America Corp DE now owns 338,915 shares of the company’s stock valued at $8,805,000 after purchasing an additional 50,621 shares in the last quarter. Antipodean Advisors LLC bought a new position in Cardlytics during the second quarter valued at $3,698,000. JPMorgan Chase & Co. lifted its position in Cardlytics by 177.9% during the second quarter. JPMorgan Chase & Co. now owns 199,301 shares of the company’s stock valued at $4,901,000 after purchasing an additional 127,596 shares during the last quarter. Finally, Royal Bank of Canada lifted its position in Cardlytics by 166.5% during the second quarter. Royal Bank of Canada now owns 10,643 shares of the company’s stock valued at $276,000 after purchasing an additional 6,649 shares during the last quarter. 93.17% of the stock is currently owned by institutional investors and hedge funds.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.

Featured Article: What is a Special Dividend?

Analyst Recommendations for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bowling Portfolio Management LLC Trims Stock Holdings in PennyMac Financial Services Inc
Bowling Portfolio Management LLC Trims Stock Holdings in PennyMac Financial Services Inc
Evertec Inc  Shares Sold by Bowling Portfolio Management LLC
Evertec Inc Shares Sold by Bowling Portfolio Management LLC
Bowling Portfolio Management LLC Increases Position in Home Depot Inc
Bowling Portfolio Management LLC Increases Position in Home Depot Inc
Bowling Portfolio Management LLC Has $1.31 Million Stake in Chevron Co.
Bowling Portfolio Management LLC Has $1.31 Million Stake in Chevron Co.
Bowling Portfolio Management LLC Has $7.92 Million Stock Position in Verizon Communications Inc.
Bowling Portfolio Management LLC Has $7.92 Million Stock Position in Verizon Communications Inc.
Orrstown Financial Services Inc. Sells 114 Shares of Home Depot Inc
Orrstown Financial Services Inc. Sells 114 Shares of Home Depot Inc


 
© 2006-2020 Zolmax.